Ptc Therapeutics (PTCT) Gross Profit (2016 - 2026)
Ptc Therapeutics (PTCT) posted quarterly Gross Profit of $340.6 million for Q2 2026, up 103.4% year-over-year from $167.5 million in Q2 2025, and up 39.29% quarter-over-quarter from $244.5 million in Q1 2026.
Ptc Therapeutics (PTCT) Gross Profit (2016 - 2026) Analysis & Trends
Ptc Therapeutics' Gross Profit history runs 11 years deep, the most recent figure standing at $340.6 million for Q2 2026.
- In Q2 2026, Gross Profit rose 103.4% year-over-year to $340.6 million; the TTM figure through Jun 2026 stood at $938.1 million (down 45.25% YoY), while the FY2025 annual figure was $1.7 billion, up 124.67% from the prior year.
- Gross Profit for Q2 2026 stood at $340.6 million, up from $244.5 million in the prior quarter.
- The five-year high for Gross Profit was $1.2 billion in Q1 2025, with the low at -$15.5 million in Q2 2024.
- The 5-year median for Gross Profit is $195.3 million (2024), against an average of $242.1 million.
- The sharpest annual moves came in 2024 and 2025: Gross Profit plunged 107.72% in 2024, then soared 1178.48% in 2025.
- Ptc Therapeutics' Gross Profit stood at $156.5 million in 2022, then soared by 77.57% to $277.9 million in 2023, then dropped by 29.16% to $196.9 million in 2024, then dropped by 19.89% to $157.7 million in 2025, then jumped by 115.94% to $340.6 million in 2026.
- Business Quant data shows PTCT's Gross Profit at $340.6 million in Q2 2026, $244.5 million in Q1 2026, and $157.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 340.60 Mn |
| Jun 30, 2026 | 340.60 Mn |
| Mar 31, 2026 | 244.52 Mn |
| Mar 31, 2026 | 244.52 Mn |
| Dec 31, 2025 | 157.73 Mn |
| Dec 31, 2025 | 157.73 Mn |
| Sep 30, 2025 | 195.23 Mn |
| Sep 30, 2025 | 195.23 Mn |
| Jun 30, 2025 | 167.46 Mn |
| Jun 30, 2025 | 167.46 Mn |
| Mar 31, 2025 | 1.16 Bn |
| Mar 31, 2025 | 1.16 Bn |
| Dec 31, 2024 | 196.89 Mn |
| Dec 31, 2024 | 196.89 Mn |
| Sep 30, 2024 | 185.94 Mn |
| Sep 30, 2024 | 185.94 Mn |
| Jun 30, 2024 | -15.53 Mn |
| Jun 30, 2024 | -15.53 Mn |
| Mar 31, 2024 | 195.38 Mn |
| Mar 31, 2024 | 195.38 Mn |